Savastano, C., & Lombardi, F. (2018). Response to Lapatinib-Capecitabine combination in a young patient with recurrent HER2-positive breast cancer refractory to two lines of therapy with anti-HER2 drugs: Risposta alla combinazione Lapatinib-Capecitabina in giovane paziente con recidiva di carcinoma della mammella HER2-positivo refrattario a due linee di terapia con farmaci anti-HER2. AboutOpen, 4(1), 162–165. https://doi.org/10.19156/abtpn.2018.0067